120017
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
牡荆属植物的植物化学特征及抗缺血性卒中作用
Received 29 November 2025
Accepted for publication 31 January 2026
Published 11 February 2026 Volume 2026:20 585338
DOI https://doi.org/10.2147/DDDT.S585338
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Anastasios Lymperopoulos
Chenqiong Xie,1 Jinjin Wu,1 Ping Huang2
1Department of Traditional Chinese Medicine Pharmacy, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2Department of Clinical Pharmacy, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China
Correspondence: Ping Huang, Department of Clinical Pharmacy, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, No. 453, Tiyuchang Road, Hangzhou, 310007, People’s Republic of China, Tel +86 18268212670, Email huangping2489@163.com
Introduction: The genus Vitex L. (Verbenaceae) comprises ~250 species globally, with long-standing ethnopharmacological value. Notably, only Traditional Chinese Medicine (TCM) explicitly applies Vitex negundo for ischemic stroke (documented in classic Materia medica), distinguishing it from other regional uses (eg, menstrual disorders, malaria) and providing a unique basis for anti-stroke research.
Materials and Methods: Through systematic searches of English and Chinese databases such as Web of Science, Pubmed, CNKI, and Wanfang Data. This review systematically summarizes the natural constituents of Vitex L. their anti-ischemic stroke efficacy, and underlying mechanisms, emphasizing the uniqueness of Vitex-specific components and guiding preclinical optimization and clinical translation.
Results: Over 200 constituents were identified, with flavonoids (vitexin, isovitexin, casticin), terpenoids (vitexilactone, rotundifuran), and phenols as core active components. High-evidence compounds (validated by both in vitro and in vivo experiments) such as vitexin (10– 50 mg/kg) reduced rat MCAO infarct volume by 30– 40% via blocking NMDA receptor-mediated Ca2⁺ overload. Mechanistically, components target neurons, glia, and vascular endothelial cells, regulating both classic pathways (Nrf2, NF-κB, PI3K/Akt) and frontier mechanisms (ferroptosis, pyroptosis, epigenetic regulation). Synergistic effects of multi-component mixtures and optimized extraction/synthesis address low-content challenges.
Conclusion: Vitex L. exhibits significant anti-ischemic stroke potential, with unique components and multi-pathway regulation as core advantages. Future research should focus on multi-center validation, synergistic mechanism exploration, and clinical trials of high-evidence components to advance translation.
Keywords: Vitex L., ischemic stroke, natural chemical constituents, neuroprotection, blood-brain barrier, flavonoid
1Department of Traditional Chinese Medicine Pharmacy, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2Department of Clinical Pharmacy, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China
Correspondence: Ping Huang, Department of Clinical Pharmacy, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, No. 453, Tiyuchang Road, Hangzhou, 310007, People’s Republic of China, Tel +86 18268212670, Email huangping2489@163.com
Introduction: The genus Vitex L. (Verbenaceae) comprises ~250 species globally, with long-standing ethnopharmacological value. Notably, only Traditional Chinese Medicine (TCM) explicitly applies Vitex negundo for ischemic stroke (documented in classic Materia medica), distinguishing it from other regional uses (eg, menstrual disorders, malaria) and providing a unique basis for anti-stroke research.
Materials and Methods: Through systematic searches of English and Chinese databases such as Web of Science, Pubmed, CNKI, and Wanfang Data. This review systematically summarizes the natural constituents of Vitex L. their anti-ischemic stroke efficacy, and underlying mechanisms, emphasizing the uniqueness of Vitex-specific components and guiding preclinical optimization and clinical translation.
Results: Over 200 constituents were identified, with flavonoids (vitexin, isovitexin, casticin), terpenoids (vitexilactone, rotundifuran), and phenols as core active components. High-evidence compounds (validated by both in vitro and in vivo experiments) such as vitexin (10– 50 mg/kg) reduced rat MCAO infarct volume by 30– 40% via blocking NMDA receptor-mediated Ca2⁺ overload. Mechanistically, components target neurons, glia, and vascular endothelial cells, regulating both classic pathways (Nrf2, NF-κB, PI3K/Akt) and frontier mechanisms (ferroptosis, pyroptosis, epigenetic regulation). Synergistic effects of multi-component mixtures and optimized extraction/synthesis address low-content challenges.
Conclusion: Vitex L. exhibits significant anti-ischemic stroke potential, with unique components and multi-pathway regulation as core advantages. Future research should focus on multi-center validation, synergistic mechanism exploration, and clinical trials of high-evidence components to advance translation.
Keywords: Vitex L., ischemic stroke, natural chemical constituents, neuroprotection, blood-brain barrier, flavonoid